tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Contineum Therapeutics, Inc. Class A (CTNM) Similar Stocks

Compare
166 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Contineum Therapeutics, Inc. Class A
$6.13
$158.59M
-61.97%
4 Buy
0 Hold
0 Sell
Strong Buy
Alnylam Pharma
$235.74
$34.10B
55.62%
18 Buy
4 Hold
0 Sell
Strong Buy
Biogen
$122.98
$19.13B
11.00
-40.10%
13 Buy
13 Hold
0 Sell
Moderate Buy
Gilead Sciences
$107.25
$140.11B
293.83
60.00%
17 Buy
6 Hold
0 Sell
Moderate Buy
Regeneron
$573.45
$67.45B
16.09
-39.62%
16 Buy
3 Hold
1 Sell
Strong Buy
Vertex Pharmaceuticals
$474.62
$124.29B
17.48%
16 Buy
10 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTNM
Contineum Therapeutics, Inc. Class A
5.80
-9.45
-61.97%
ALNY
Alnylam Pharma
235.74
82.18
53.52%
BIIB
Biogen
122.98
-80.89
-39.68%
GILD
Gilead Sciences
107.25
40.19
59.93%
REGN
Regeneron
573.45
-368.04
-39.09%
VRTX
Vertex Pharmaceuticals
474.62
67.95
16.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis